StockWatch
·

Concord Biotech Ltd Q2 FY26 Results

CONCORDBIOQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue247.0621.1%20.4%
Total Income260.4119.6%18.7%
Expenditure177.0210.3%5.3%
PBT83.3945.7%37.4%
Net Profit63.0643.1%34.1%
OPM35.82%5.72pp0.40pp
NPM24.22%3.98pp6.60pp
EPS6.0343.2%34.1%
View full financials

Informational and educational content only. Not investment advice.